Dispute between the u. S. And china intensifies. On the 1st friday prayers at istanbuls after its controversial change of status from the museum to a mosque. Helo more than 6 months since the corona virus was 1st detected in china the pandemic is still ripping through the world at record rates more than 284000 new infections have been reported in the last 24 hours thats a record rise according to the World Health Organization nearly 10000. 00 people have died in that same period the biggest spike since the end of april in europe kovan 1000. 00 is resurging in spain and france french citizens are now advised not to travel to the spanish region of catalonia which has recorded more than 8000 cases in the past fortnight and france is warning that its own outbreak may be accelerating reporting a fellows of 130. 00 cases in the last 24 hours alone. Well the outbreak in the us continues to worsen with more than 8100 new deaths on thursday alone florida is one of the worst hit states and its r
Share this article
Share this article
USD$900,000 In-Kind Investment by Procare Health into Phase I Clinical Study for BVX-0918A in the EU
Co-Development of Vaccines for Cervical Cancer and HPV
Right of First Refusal for US Marketing of Papilocare™
VANCOUVER, BC and BARCELONA, Spain, Feb. 10, 2021 /PRNewswire/ BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF)
( BioVaxys ), the world leader in haptenized protein vaccines for antiviral and cancer applications, and Procare Health Iberia, S.L., of Barcelona, Spain ( Procare Health ), a leading privately-held European pharmaceutical company, announced today that they have entered into a broad collaboration for the co-development, joint commercialization, and marketing of BioVaxys vaccines for ovarian cancer, cervical cancer, and human papilloma virus ( HPV ), and the right of first refusal for marketing by BioVaxys in the United States of Procare Health s vaginal gel product, Papilocare
Glenmede Investment Management Celebrates 5th Anniversary for Women in Leadership U.S. Equity Strategy
Glenmede Investment Management Celebrates 5th Anniversary for Women in Leadership U.S. Equity Strategy Glenmede Investment Management LP (GIM), a privately owned, independent asset management firm, recently celebrated the five-year anniversary of its Glenmede Women in Leadership US Equity Strategy (Strategy). With more than $25.6 million in assets under management as of September 30, 2020, the strategy is a portfolio of large cap stocks, constructed with proprietary multi-factor models, based on a universe of securities with women in various positions of leadership. The strategys investment universe consists of equities of companies which meet an identified percentage of gender diversity in senior management and board membership. Since its inception in December 2015, Glenmedes Women in Leadership U.S. Equity Strategy increased its requirements by 5%. Currently, the strategy re